Parkinsonian speech disfluencies: effects of l-dopa-related fluctuations (Q44411134)

2 December 2017

Parkinsonian speech disfluencies: effects of L-dopa-related fluctuations (English)

1 reference

2 December 2017

Parkinsonian speech disfluencies: effects of l-dopa-related fluctuations (English)

1 reference

https://api.crossref.org/works/10.1016/S0094-730X(03)00005-6

26 December 2023

1 reference

Linguistics and Language

1 reference

https://api.crossref.org/works/10.1016/S0094-730X(03)00005-6

26 December 2023

author name string

Michael Blomgren

2

1 reference

2 December 2017

Alexander M. Goberman

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12706913

26 December 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=12706913

26 December 2023

publication date

1 January 2003

1 reference

full work available at URL

2 December 2017

https://api.elsevier.com/content/article/PII:S0094730X03000056?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0094-730X(03)00005-6

https://api.elsevier.com/content/article/PII:S0094730X03000056?httpAccept=text/plain

26 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0094-730X(03)00005-6

Journal of Fluency Disorders

26 December 2023

published in

1 reference

2 December 2017

28

1 reference

2 December 2017

1

1 reference

2 December 2017

55-70

1 reference

Developmental stuttering and Parkinson's disease: the effects of levodopa treatment

2 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Effect of extended exposure to frequency-altered feedback on stuttering during reading and monologue

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Metric properties of nurses' ratings of parkinsonian signs with a modified Unified Parkinson's Disease Rating Scale.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Altered patterns of cerebral activity during speech and language production in developmental stuttering. An H2(15)O positron emission tomography study.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Subcortical infarction resulting in acquired stuttering

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

A positron emission tomography study of silent and oral single word reading in stuttering and nonstuttering adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Management of response fluctuations: practical guidelines

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Phonatory characteristics of parkinsonian speech before and after morning medication: the ON and OFF states.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Functional-lesion investigation of developmental stuttering with positron emission tomography

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Levodopa peripheral pharmacokinetics and duration of motor response in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Dysfluency (stuttering) in extrapyramidal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Adult onset of stuttering as a presenting sign in a parkinsonian-like syndrome: a case report

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Speech dysfluency exacerbated by levodopa in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Stuttering: neuropsychiatric features measured by content analysis of speech and the effect of risperidone on stuttering severity

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Risperidone for the treatment of stuttering

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Haloperidol in the Treatment of Stuttering

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Early introduction of dopamine agonists in the long-term treatment of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Principal and differential effects of haoperidol and placebo treatments upon speech disfuluencies in stutterers

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

The effect of haloperidol on stuttering

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Re-emergence of childhood stuttering in Parkinson's disease: a hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Increased dopamine activity associated with stuttering

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

Judgments of disfluency by mothers of stuttering and normally fluent children.

1 reference

https://api.crossref.org/works/10.1016%2FS0094-730X%2803%2900005-6

7 January 2021

The acute effect of haloperidol and apomorphine on the severity of stuttering

8

1 reference

https://api.crossref.org/works/10.1016/S0094-730X(03)00005-6

Stuttering: a brief review

26 December 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0094-730X(03)00005-6

26 December 2023

Identifiers

1 reference

2 December 2017

1 reference